Wave Life Sciences (WVE) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Wave Life Sciences (WVE) over the last 10 years, with Q4 2024 value amounting to $46.3 million.
- Wave Life Sciences' Accumulated Depreciation & Amortization rose 847.6% to $46.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $46.3 million, marking a year-over-year increase of 847.6%. This contributed to the annual value of $46.3 million for FY2024, which is 847.6% up from last year.
- According to the latest figures from Q4 2024, Wave Life Sciences' Accumulated Depreciation & Amortization is $46.3 million, which was up 847.6% from $42.7 million recorded in Q4 2023.
- In the past 5 years, Wave Life Sciences' Accumulated Depreciation & Amortization ranged from a high of $46.3 million in Q4 2024 and a low of $24.9 million during Q4 2020
- Its 5-year average for Accumulated Depreciation & Amortization is $36.8 million, with a median of $37.8 million in 2022.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 4640.95% in 2020, then soared by 847.6% in 2024.
- Quarter analysis of 5 years shows Wave Life Sciences' Accumulated Depreciation & Amortization stood at $24.9 million in 2020, then rose by 29.47% to $32.2 million in 2021, then grew by 17.42% to $37.8 million in 2022, then grew by 12.85% to $42.7 million in 2023, then grew by 8.48% to $46.3 million in 2024.
- Its last three reported values are $46.3 million in Q4 2024, $42.7 million for Q4 2023, and $37.8 million during Q4 2022.